NEW YORK (GenomeWeb News) – Axxam has licensed Genedata’s data analysis and management software for use in its high-throughput screening programs, Genedata said today.
The multi-year agreement allows Axxam to implement the Genedata Screener software.
Axxam CEO Stefan Lohmer said the company’s focus extends beyond the actual license agreement to “a comprehensive, long-term partnership in high throughput screening.”
Genedata said the Screener’s architecture integrates with Axxam’s existing infrastructures and that it can be tailored for specific discovery processes.
Financial terms of the agreement were not released.